EHD2 and intrahepatic cholangiocarcinoma: Data from the TCGA database also showed that EHD2 was overexpressed in other cancer types such as esophageal carcinoma (ESCA), kidney renal clear-cell carcinoma (KIRC), and intrahepatic cholangiocarcinoma (ICC) (Supplementary Fig. 7b).